Last reviewed · How we verify
NCT04681664
Gut Microbiome Based Analysis of High Protein High Fat Diet
NA trial testing High fat diet in Obesity in 78 participants. Completed in 30 November 2017.
30 September 2017
Quick facts
| Lead sponsor | Center of Food and Fermentation Technologies |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 78 |
| Start date | 1 April 2017 |
| Primary completion | 30 September 2017 |
| Estimated completion | 30 November 2017 |
| Sites | 1 location across Estonia |
Drugs / interventions tested
- High fat diet
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Center of Food and Fermentation Technologies
Who can join
Adults 20 to 55, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to determine body mass reduction and microbiota composition change after the weight loss diet (50 % fat, 25 % proteins and 25 % carbohydrates).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04681664
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High fat diet
Trials testing the same drug.
- NCT05965973 — Diet Impact on Hepatic Transcriptomics and Lipidomics in Pre-diabetes · NA · active not recruiting
- NCT03382756 — A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337 · Phase 1 · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Center of Food and Fermentation Technologies trials
Trials by the same sponsor.
- NCT05424640 — Dietary Fiber and Gut Microbiome Study · NA · completed
- NCT04811157 — The Effect of Functional Dairy Products Enriched With Dietary Fibers on Human Health and Gut Microbiota · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04681664 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Center of Food and Fermentation Technologies
- Last refreshed: 23 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04681664.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing